Abstracts

Abstracts This content is only available as a PDF. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Heart Journal Oxford University Press

Abstracts

European Heart Journal , Volume 23 (Abstract_Supplement) – Aug 1, 2002

Abstracts

Day 2 Sunday 1 September 2002 Downloaded from https://academic.oup.com/eurheartj/article-abstract/23/Abstract_Supplement/1/586433 by Ed 'DeepDyve' Gillespie user on 04 February 2018 Resynchronisation therapy in heart failure: are we doing any good? RESYNCHRONISATION THERAPY IN HEART FAILURE 79 Cardiac resynchronisation therapy — a cost effective treatment for cardiac failure ARE WE DOING ANY GOOD? L J. Dixon, G. Thompson, M. Harbinson, G. Murtagh, G. Richardson, E.W. Chew. Regional Cardiology Centre, Belfast City Hospital, Belfast, United 77 Sustained clinical efficacy of biventricular pacing in sinus Kingdom rhythm patients: 2 years follow-up from the MUSTIC study Health care costs for heart failure are substantial.lt is the leading medical cause C. Leclercq', C. Linde 2 , S. Cazeau 3 , L. Kappenberger 4 , R. Sutton 5 , of hospitilisation, accounting for 5% of acute admissions. Heart failure admis- C. Bailleu1 6 , C. Daubert' on behalf of MUSTIC Study Group. t University sions are lengthly,and readmission rates are high, with 20% of patients read- Hospital, Cardiology, Rennes, France; 2 Karolinska Hospital, Stockholm, mitted within 30 days, and 50% within 3 months. It consumes 2% of the Na- Sweden; 3 St Cloud, France; 'Lausanne, Switzerland; 'London, United tional Health Service budget. Hospital treatment constitutes 65-75% of these 6Le Plessis Robinson, France Kingdom; costs.Against this background of limited resources, and the need for alternative Background: Previous controlled and randomized studies have shown that treatment options, cardiac resynchronisation therapy has emerged. biventricular pacing improved short term (3 to 6 months) functional status in 30-50% of patients with cardiac failure are suitable for resynchronisation ther- patients with advanced heart failure, intraventricular conduction delay and left apy. 41 patients have received cardiac resynchronisation therapy in the Belfast ventricular systolic...
Loading next page...
 
/lp/ou_press/abstracts-HKItGkKhG1
Publisher
Oxford University Press
ISSN
0195-668X
eISSN
1522-9645
D.O.I.
10.1093/eurheartj/23.Abstract_Supplement.1
Publisher site
See Article on Publisher Site

Abstract

This content is only available as a PDF.

Journal

European Heart JournalOxford University Press

Published: Aug 1, 2002

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial